Clinical Trial Update: Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC [Phase 1]

View source ↗

Summary

Phase I trial evaluating apalutamide in combination with abiraterone acetate, docetaxel, and prednisone in patients with metastatic castration-resistant prostat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Apalutamide (apalutamide)
• DOCETAXEL (DOCETAXEL)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Prostate Cancer Metastatic | Phase 1 | Status: COMPLETED